Tobira Therapeutics
Get Full AccessDescription
- Tobira is focused on developing and commercializing innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV-1, fibrosis and inflammation. Its lead product candidate, cenicriviroc, or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. Tobiras management team has extensive experience in developing and commercializing therapeutics for liver disease and HIV-1.The lead indication for CVC is non-alcoholic steatohepatitis, or NASH, for which Tobira plans to begin a Phase 2 clinical trial in the second half of 2014. The company believes there are no other product candidates in development for NASH that target the immuno-inflammatory pathways responsible for fibrosis.CVC also is Phase 3-ready in HIV-1 infection with potential as the backbone in a fixed-dose combination therapy. CVC is a once-daily pill with a safety and tolerability profile that has been established to date in 550 subjects dosed in completed Phase 1 and Phase 2 trials, including 115 HIV-1 infected subjects on treatment for up to 48 weeks.
-
Headquarters:701 Gateway Boulevard Suite 300, South San Francisco, California, United States
More -
Phone Number: +1 650-741-6625
-
Website: https://www.tobiratherapeutics.com
-
Employees:6
-
Revenue:$1 - 10M
-
Legal Name:Tobira Therapeutics
-
Tobira Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 621399 |
Show More
Frequently Asked Questions regarding Tobira Therapeutics
-
Where are Tobira Therapeutics's Headquarters?
Tobira Therapeutics's Headquarters are in 701 Gateway Boulevard Suite 300,South San Francisco,California,United States
-
What is Tobira Therapeutics's phone number?
Tobira Therapeutics's phone number is +1 650-741-6625
-
What is Tobira Therapeutics's official website?
Tobira Therapeutics's official website is https://www.tobiratherapeutics.com
-
What is Tobira Therapeutics's Revenue?
Tobira Therapeutics's revenue is $1 - 10M
-
What is Tobira Therapeutics's NAICS code?
Tobira Therapeutics's NAICS code is 621399
-
How many employees are working in Tobira Therapeutics
Tobira Therapeutics has 6 employees
-
What is Tobira Therapeutics's Industry?
Tobira Therapeutics is in the industry of Biotechnology
-
Who is Tobira Therapeutics's Director, Quality Assurance?
Tobira Therapeutics's Director, Quality Assurance is Cliff Sachs

